| Date Filed | Type | Description |
| 09/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/25/2023 |
4
| Williams Leslie J. (Director) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/|
Txns:
| Granted 2,033 shares
@ $0
Granted 3,050 options to buy
@ $1.21, valued at
$3.7k
|
|
| 08/25/2023 |
4
| Strobeck Mark (Director) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/|
Txns:
| Granted 2,300 shares
@ $0
Granted 3,450 options to buy
@ $1.21, valued at
$4.2k
|
|
| 08/25/2023 |
4
| SCOTT ROBERT A (Director) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/|
Txns:
| Granted 2,033 shares
@ $0
Granted 3,050 options to buy
@ $1.21, valued at
$3.7k
|
|
| 08/25/2023 |
4
| Simonson Steven (SVP, Chief Medical Officer) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/|
Txns:
| Granted 15,867 shares
@ $0
Granted 23,800 options to buy
@ $1.21, valued at
$28.8k
|
|
| 08/25/2023 |
4
| Curtis Eric (SVP & COO) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/|
Txns:
| Granted 14,667 shares
@ $0
Granted 22,000 options to buy
@ $1.21, valued at
$26.6k
|
|
| 08/25/2023 |
4
| Fraser Craig (President and CEO) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/|
Txns:
| Granted 45,867 shares
@ $0
Granted 68,800 options to buy
@ $1.21, valued at
$83.2k
|
|
| 08/16/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/07/2023 |
8-K
| Quarterly results |
| 08/07/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 06/28/2023 |
3
| Strobeck Mark (Director) has filed a Form 3 on WINDTREE THERAPEUTICS INC /DE/ |
| 05/31/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/19/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 05/19/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 05/17/2023 |
SC 13D/A
| Huang James reports a 1.5% stake in Windtree Therapeutics, Inc. |
| 05/01/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
| 04/28/2023 |
SC 13G
| Lind Global Fund II LP reports a 9.9% stake in Windtree Therapeutics, Inc. |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/24/2023 |
8-K
| Quarterly results |
| 04/24/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/20/2023 |
424B4
| Form 424B4 - Prospectus [Rule 424(b)(4)]: |
| 04/20/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 04/19/2023 |
S-1MEF
| Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]: |
| 04/19/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/19/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 04/19/2023 |
8-K
| Quarterly results |
| 04/13/2023 |
FWP
| Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses: |
| 04/13/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 04/03/2023 |
8-K
| Quarterly results |
| 03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/13/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 03/02/2023 |
4
| Simonson Steven (SVP, Chief Medical Officer) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/|
Txns:
| Paid exercise price by delivering 100 shares
@ $0 |
|
|